An update of congenital adrenal hyperplasia

Annals of the New York Academy of Sciences

Volumn 1038, Issue , 2004, Pages 14-43

  New, Maria I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

21 hydroxylase deficiency; CAH; Congenital adrenal hyperplasia; Salt wasting; Steroid synthesis

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CYTOCHROME P450; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG;

ACNE CYSTICA; ADENOHYPOPHYSIS; ALOPECIA; AMENORRHEA; AUTOSOMAL RECESSIVE DISORDER; BONE AGE; CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; ETHNIC DIFFERENCE; FEEDBACK SYSTEM; FEMALE INFERTILITY; FEMALE PSEUDOHERMAPHRODITISM; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; GROWTH ACCELERATION; HIRSUTISM; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERANDROGENISM; JEW; MALE INFERTILITY; MENARCHE; OLIGOSPERMIA; OVARY POLYCYSTIC DISEASE; PRENATAL DIAGNOSIS; SEXUAL DEVELOPMENT; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROIDOGENESIS; VIRILIZATION;

EID: 17744365980     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1315.009     Document Type: Conference Paper

References (147)

1. DE CRECCHIO, L. 1865. Sopra un caso di apparenzi virili in una donna. Morgagni 7: 154-188.
2. GANONG, W. 1963. The central nervous system and the synthesis and release of adrenocorticotrophic hormone. In Advances in Neuroendocrinology. A. Nalbandov, Ed.: 92. University of Illinois Press. Urbana.
3. GUILLEMIN, R. & A. SCHALLY. 1963. Recent advances in the chemistry of neuroendocrine mediators originating in the central nervous system. In Advances in Neuroendocrinology. A. Nalbandov, Ed.: 314. University of Illinois Press. Urbana.
4. WILKINS, L. 1962. Adrenal disorders. II. Congenital virilizing adrenal hyperplasia. Arch. Dis. Child 37: 231.
5. PRADER, A., M. ZACHMANN & R. ILLIG. 1977. Normal spermatogenesis in adult males with congenital adrenal hyperplasia after discontinuation of therapy. In Congenital Adrenal Hyperplasia. P. Lee, L. Platnick, A. Kowarski & C. Migeo, Eds.: 397. University Park Press. Baltimore.
6. SIMARD, J., E. RHEAUME, F. MEBARKI, et al. 1995. Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency. J. Steroid Biochem. Mol. Biol. 53: 127-138.
7. MOISAN, A., M. RICKETTS, V. TARDY, et al. 1999. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J. Clin. Endocrinol. Metab. 84: 4410-4425.
8. ZERAH, M., E. RHEAUME, P. MANI, et al. 1994. No evidence of mutations in the genes for type I and type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) in nonclassical 3 beta HSD deficiency. J. Clin. Endocrinol. Metab. 79: 1811-1817.
9. TAJIMA, T., Y. NISHI, A. TAKASE, et al. 1997. No genetic mutation in type II 3 beta-hydroxysteroid dehydrogenase gene in patients with biochemical evidence of enzyme deficiency. Horm. Res. 47: 49-53.
10. YANASE, T., E. SIMPSON & M. WATERMAN. 1991. 17 alpha-hydroxylase/17, 20-lyase deficiency: from clinical investigation to molecular definition. Endocrin. Rev. 12: 91-108.
11. LIN, D., T. SUGAWARA, J.F. STRAUSS 3rd, et al. 1995. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267: 1821-1831.
12. BOSE, H., T. SUGAWARA, J.F. STRAUSS 3rd & W. MILLER. 1996. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N. Engl. J. Med. 335: 1870-1878.
13. STOCCO, D. & B. CLARK. 1997. The role of the steroidogenic acute regulatory protein in steroidogenesis. Steroids 62: 29-36.
14. LEVINE, L.S., M.I. NEW, P. PITT & R.E. PETERSON. 1972. Androgen production in boys with sexual precocity and congenital adrenal hyperplasia. Metabolism 21: 457-464.
15. LIPPE, B., F.S. LA, N. LAVIN, et al. 1974. Serum 17-alpha- hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia. J. Pediatr. 85: 782-787.
16. JANNE, O., J. PERHEENTUPA, L. VIINIKKA & R. VIHKO. 1975. Plasma pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone and 5alpha-dihydrotestosterone in different types of congenital adrenal hyperplasia. Clin. Endocrinol. (Oxf) 4: 39-48.
17. SOLOMON, I., E. SCHOEN, L. DONELAN & D. BRANDT-ERICHSEN. 1975. Blood testosterone values in patients with congenital virilizing adrenal hyperplasia. J. Clin. Endocrinol. Metab. 40: 355-362.
18. HUGHES, I. & J. WINTER. 1976. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia. J. Pediatr. 88: 766-773.
19. PANG, S., J. HOTCHKISS, A.L. DRASH, et al. 1977. Microfilter paper method for 17-hydroxyprogesterone radioimmunassay. J. Clin. Endocrinol. Metab. 45: 1003-1008.
20. KORTH-SCHUTZ, S., R. VIRDIS, P. SAENGER, et al. 1978. Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 46: 452-458.
21. PANG, S., L.S. LEVINE, D.M. CHOW, et al. 1979. Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf) 11: 575-584.
22. BONGIOVANNI, A.M., W.R. EBERLEIN & J. CARA. 1954. Studies on metabolism of adrenal steroids in adrenogenital syndrome. J. Clin. Endocrinol. Metab. 14: 409.
23. BUTLER, G.C. & G.F. MARRIAN. 1937. The isolation of pregnane-3,17,20-triol from the urine of women showing the adrenogenital syndrome. J. Biol. Chem. 119: 565.
24. GHIZZONI, L., G. MASTORAKOS, A. VOTTERO, et al. 1996. Spontaneous cortisol and growth hormone secretion interactions in patients with nonclassic 21-hydroxylase deficiency (NCCAH) and control children. J. Clin. Endocrinol. Metab. 81: 482-487.
25. GHIZZONI, L., G. MASTORAKOS, M. STREET, et al. 1997. Spontaneous thyrotropin and cortisol secretion interactions in patients with nonclassical 21-hydroxylase deficiency and control children. J. Clin. Endocrinol. Metab. 82: 3677-3683.
26. NEW, M. & L. LEVINE. 1981. Adrenal hyperplasia in intersex states. In Pediatric and Adolescent Endocrinology. Z. Laron & P. Tikva, Eds., Vol. 8: 51. S. Karger. Basel.
27. KLEIN, R. 1960. Evidence for and evidence against the existence of a salt-losing hormone. J. Pediatr. 57: 452.
28. KOWARSKI, A., J. FINKELSTEIN, J. SPAULDING, et al. 1965. Aldosterone secretion rate in congenital adrenal hyperplasia. A discussion of the theories on the pathogenesis of the salt-losing form of the syndrome. J. Clin. Invest. 44: 1505.
29. KUHNLE, U., M. LAND & S. ULICK. 1986. Evidence for the secretion of an anti-mineralocorticoid in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 62: 934-940.
30. STONER, E., J. DIMARTINO-NARDI, U. KUHNLE, et al. 1986. Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect? Clin. Endocrinol. (Oxf) 24: 9-20.
31. LUETSCHER, J.A. 1956. Studies of aldosterone in relation to water and electrolyte balance in man. Recent Prog. Horm. Res. 12: 175.
32. SPEISER, P.W., L. AGDERE, H. UESHIBA, et al. 1991. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. N. Engl. J. Med. 324: 145-149.
33. VERKAUF, B. & H.J. JONES. 1970. Masculinization of the female genitalia in congenital adrenal hyperplasia: relationship to the salt losing variety of the disease. South Med. J 63: 634-638.
34. JONES, H. & G. JONES. 1954. The gynecological aspects of adrenal hyperplasia and allied disorders. Am. J. Obstet. Gynecol. 68: 1330.
35. JEFFERIES, W., W. WEIR, D. WEIR & R. PROUTY. 1958. The use of cortisone and related steroids in infertility. Fertil. Steril. 9: 145.
36. DECOURT, M.J., M.F. JAYLE & E. BAULIEU. 1957. Virilisme cliniquement tardif avec excretion de pregnanetriol et insuffisance de la production du cortisol. Ann. Endocrinol. (Paris) 18: 416.
37. FRASIER, S., I. THORNEYCROFT, B. WEISS & R. HORTON. 1975. Letter: Elevated amniotic fluid concentration of 17 alpha-hydroxyprogesterone in congenital adrenal hyperplasia. J. Pediatr. 86: 310-312.
38. LEVINE, L.S., B. DUPONT, F. LORENZEN, et al. 1980. Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 51: 1316-1324.
39. KOHN, B., L.S. LEVINE, M.S. POLLACK, et al. 1982. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 55: 817-827.
40. ROSENWAKS, Z., P.A. LEE, G.S. JONES, et al. 1979. An attenuated form of congenital virilizing adrenal hyperplasia. J. Clin. Endocrinol. Metab. 49: 335.
41. POLLACK, M.S., L.S. LEVINE, G.J. O'NEILL, et al. 1981. HLA linkage and B14, DR1. BfS haplotype assocation with the genes for late onset and cryptic 21-hydroxylase deficiency. Am. J. Hum. Genet. 33.
42. LARON, Z., M.S. POLLACK, R. ZAMIR, et al. 1980. Late-onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus. Hum. Immunol. 1: 55-66.
43. LEVINE, L.S., B. DUPONT, F. LORENZEN, et al. 1981. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 53: 1193-1198.
44. BLANKSTEIN, J., C. FAIMAN, F.I. REUES, et al. 1980. Adult-onset familial adrenal 21-hydroxylase deficiency. Am. J. Med. 68: 441.
45. MIGEON, C.J., Z. ROSENWAKS, P.A. LEE, et al. 1980. The attenuated form of congenital adrenal hyperplasia as an allelic form of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 51: 647.
46. SPEISER, P.W., B. DUPONT, P. RUBINSTEIN, et al. 1985. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 37: 650-667.
47. DUMIC, M., L. BRKLJACIC, P.W. SPEISER, et al. 1990. An update on the frequency of nonclassical deficiency of adrenal 21-hydroxylase in the Yugoslav population. Acta Endocrinol. 122: 703-710.
48. TEMECK, J.W., S.Y. PANG, C. NELSON & M.I. NEW. 1987. Genetic defects of steroidogenesis in premature pubarche. J. Clin. Endocrinol. Metab. 64: 609-617.
49. HAWKINS, L., F. CHASALOW & S. BLETHEN. 1992. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea. J. Clin. Endocrinol. Metab. 74: 248-253.
50. NEW, M.I., J.M. GERTNER, P.W. SPEISER & P. DEL BALZO. 1991. Growth and final height in congenital adrenal hyperplasia (classical 21-hydroxylase deficiency) and in nonclassical 21-hydroxylase deficiency. In Growth Disorders: The State of the Art. L. Cavallo, J.C. Job & M.I. New, Eds. Vol. 81: 105-110. Raven Press. New York City.
51. LUCKY, A., R. ROSENFIELD, J. MCGUIRE, et al. 1986. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J. Clin. Endocrinol. Metab. 62: 840-848.
52. ROSE, L., S. NEWMARK, J. STRAUSS & P. POCHI. 1976. Adrenocortical hydroxylase deficiencies in acne vulgaris. J. Invest. Dermatol. 66: 324-326.
53. ODRISCOLL, J. & D. ANDERSON. 1993. Untreated congenital adrenal hyperplasia. J. Royal Soc. Med. 86: 229.
54. PANG, S.Y, A.J. LERNER, E. STONER, et al. 1985. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J. Clin. Endocrinol. Metab. 60: 428-439.
55. CHILD, D., D. BU'LOCK & D. ANDERSON. 1980. Adrenal steroidogenesis in hirsute women. Clin. Endocrinol. (Oxf) 12: 595-601.
56. GIBSON, M., R. LACKRITZ, I. SCHIFF & D. TULCHINSKY. 1980. Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women. Fertil. Steril. 33: 43-48.
57. LOBO, R. & U. GOEBELSMANN. 1980. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. Am . J. Obstet. Gynecol. 138: 720-726.
58. CHROUSOS, G., D. LORIAUX, D. MANN & G.J. CUTLER. 1982. Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations. Horm. Res. 16: 193-200.
59. KUTTENN, F., P. COUILLIN, F. GIRARD, et al. 1985. Late-onset adrenal hyperplasia in hirsutism. N. Engl. J. Med. 313: 224-231.
60. CHROUSOS, G.P., D.L. LORIAUX, R.J. SHERINES & G.B. CUTLER. 1981. Unilateral testicular enlargement resulting from inapparent 21-hydroxylase deficiency. J. Urol. 126: 127.
61. WISCHUSEN, J., H.W.G. BAKER & B. HUDSON. 1981. Reversible male infertility due to congenital adrenal hyperplasia. Clin. Endocrinol. 14: 571.
62. BONACCORSI, A.C., I. ADLER & J.G. FIGUEIREDO. 1987. Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. Fertil. Steril. 47: 664-670.
63. AUGARTAN, A., R. WEISSENBERG, C. PARIENTE & J. SACK. 1991. Reversible male infertility in late onset congenital adrenal hyperplasia. J. Endocrinol. Invest. 14: 237-240.
64. MOKSHAGUNDAM, S. & M. SURKS. 1993. Congenital adrenal hyperplasia diagnosed in a man during workup for bilateral adrenal masses. Arch. Intern. Med. 153: 1389-1391.
65. JARESCH, S., E. KORNELY, H. KLEY & R. SCHLAGHECKE. 1992. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 74: 685-689.
66. JONES, H. & B. VERKAUF. 1971. Congenital adrenal hyperplasia: age at menarche and related events at puberty. Am. J. Obstet. Gynecol. 109: 292.
67. KLINGENSMITH, G., S. GARCIA, H. JONES, et al. 1977. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J. Pediatr. 90: 996-1004.
68. PANG, S. et al. 1977. Growth and sexual maturation and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. In Congenital Adrenal Hyperplasia. P. Lee et al., Eds.: 233-246. University Park Press. Baltimore.
69. GHALI, I., M. DAVID & L. DAVID. 1977. Linear growth and pubertal development in treated congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf) 6: 425-436.
70. REITER, E., M. GRUMBACH, S. KAPLAN & F. CONTE. 1975. The response of pituitary gonadotropes to synthetic LRF in children with glucocorticoid-treated congenital adrenal hyperplasia: lack of effect of intrauterine and neonatal androgen excess. J. Clin. Endocrinol. Metab. 40: 318-325.
71. KIRKLAND, J., R. KIRKLAND, L. LIBRIK & G. CLAYTON. 1974. Serum gonadotropin levels in female adolescents with congenital adrenal hyperplasia. J. Pediatr. 84: 411-414.
72. WENTZ, A., S. GARCIA, G. KLINGENSMITH, et al. 1977. Hypothalamic maturation in congenital adrenal hyperplasia. In Congenital Adrenal Hyperplasia. P. Lee, L. Plotnick, A. Kowarski & C. Migeon, Eds.: 379. University Park Press. Baltimore.
73. LEVIN, J., E. CARMINA & R. LOBO. 1991. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia? Fertil. Steril. 56: 635-640.
74. PESCOVITZ, O., F. COMITE, F. CASSORLA, et al. 1984. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J. Clin. Endocrinol. Metab. 58: 857-861.
75. DACOU-VOUTETAKIS, C. & N. KARIDIS. 1993. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue. Ann. N.Y. Acad. Sci. 687: 250-254.
76. SOLIMAN, A.T., M. AL LAMKI, I. AL SALMI & M. ASFOUR. 1997. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism 46: 513-517.
77. QUINTOS, J., M. VOGIATZI, M. HARBISON & M. NEW. 1999. Growth hormone and depot leuprolide therapy for short stature in children with congenital adrenal hyperplasia. 81st Annual Meeting of The Endocrine Society. San Diego, CA.
78. WILKINS, L., J. CRIGLER, S. SILVERMAN, et al. 1952. Further studies on the treatment of congenital adrenal hyperplasia with cortisone. II. The effects of cortisone on sexual and somatic development, with an hypothesis concerning the mechanism of feminization. J. Clin. Endocrinol. Metab. 12: 277.
79. KLINGENSMITH, G., A. WENTZ, W. MEYER & C. MIGEON. 1976. Gonadotropin output in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 43: 933.
80. KIESSLIN, G. & G. SCHWARZ. 1966. Zur genese des hypogonadismus beim kongenitalen adrenogenitalen syndrome. Arch. Klin. Dermatol. 228: 684.
81. KIRKLAND, R., B. KEENAN & G. CLAYTON. 1977. Long-term follow-up of patients with congenital adrenal hyperplasia in Houston. In Congenital Adrenal Hyperplasia P. Lee, L. Plotnick, A. Kowarski & C. Migeon, Eds.: 273. University Park Press. Baltimore.
82. RICHARDS, G., M. GRUMBACH, S. KAPLAN & F. CONTE. 1978. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 47: 1208-1215.
83. RICHARDS, G., D. STYNE, F. CONTE, et al. 1977. Plasma sex steroids and gonadotropins in pubertal girls with congenital adrenal hyperplasia: relationship to menstrual disorders. In Congenital Adrenal Hyperplasia. P. Lee, L. Plotnick, A. Kowarski & C. Migeon, Eds.: 233. University Park Press. Baltimore.
84. GRAYZEL, E. 1974. Postpubertal adrenogenital syndrome. Treatable cause of infertility. N. Y. State J. Med. 74: 1038-1039.
85. GRANOFF, A. 1981. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia. J. Adolesc. Health Care 2: 23-27.
86. ROSENFIELD, R., S. BICKEL & A. RAZDAN. 1980. Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet. Gynecol. 56: 208-215.
87. RIDDICK, D. & C. HAMMOND. 1975. Adrenal virilism due to 21-hydroxylase deficiency in the postmenarchial female. Obstet. Gynecol. 45: 21-24.
88. MORI, M. 1970. Congenital adreogenital syndrome and successful pregnancy: report of a case. J. Obstet. Gynecol. 35: 394.
89. LO, J., V. SCHWITZGEBEL, J. TYRRELL, et al. 1999. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 84: 930-936.
90. MULAIKAL, R.M., C.J. MIGEON & J.A. ROCK. 1987. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med. 316: 178-182.
91. PREMAWARDHANA, L., I. HUGHES, G. READ & M. SCANLON. 1997. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin. Endocrinol. (Oxf) 46: 327-332.
92. STEWART, J. 1960. A fertile male with untreated congenital adrenal hyperplasia. Acta Endocrinol. (Suppl.) 51: 661.
93. URBAN, M, P. LEE & C. MIGEON. 1978. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N. Engl. J. Med. 299: 1392.
94. VALENTINO, R., S. SAVASTANO, A. TOMMASELLI, et al. 1997. Success of glucocorticoid replacement therapy on fertility in two adult males with 21-CAH homozygote classic form. J. Endocrinol. Invest. 20: 690-694.
95. MOLITOR, J., B. CHERTOW & B. FARISS. 1973. Long-term follow-up of a patient with congenital adrenal hyperplasia and failure of testicular development. Fertil. Steril. 24: 319.
96. BAHNER, F. & G. SCHWARZ. 1961. Congenitale nebennierenrinden hyperplasie beim mann mit normaler keimdrusenfunktion und fertilitat. Acta Endocrinol. 38: 236.
97. WILKINS, L. 1965. The Diagnosis and Treatment of Endocrine Disorders. Charles C. Thomas. Springfield, IL, pp. 368-381.
98. RAITI, S., N. MACLAREN & F. AKESODE. 1977. Gonadotropin-adrenal- testicular axis in males with congenital adrenal hyperplasia and idiopathic sexual precocity. In Congenital Adrenal Hyperplasia. P. Lee, L. Plotnick, A. Kowarski & C. Migeon, Eds.: 403. University Park Press. Baltimore.
99. BLUMBERG-TICK, J., P. BOUDOU, K. NAHOUL & G. SCHAISON. 1991. Testicular tumors in congenital adrenal hyperplasia: steroid measurements from adrenal and spermatic veins. J. Clin. Endocrinol. Metab. 73: 1129-1133.
100. SCHOEN, E., V. DIRAIMONDO & O. DOMINGUEZ. 1961. Bilateral testicular tumors complicating congenital adrenocortical hyperplasia. J. Clin. Endocrinol. Metab. 21: 518.
101. MILLER, E. & H. MURRAY. 1962. Congenital adrenocortical hyperplasia: case previously reported as "bilateral interstitial cell tumor of the testicle". J. Clin. Endocrinol. Metab. 22: 655.
102. GLENN, J. & W. BOYCE. 1963. Adrenogenitalism with testicular adrenal rests simulating interstitial cell tumor. J. Urol. 89: 456.
103. RADFAR, N., F. BARTTER, R. EASLEY, et al. 1977. Evidence for endogenous LH suppression in a man with bilateral testicular tumors and congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 45: 1194-1204.
104. SRIKANTH, M., B. WEST, M. ISHITANI, et al. 1992. Benign testicular tumors in children with congenital adrenal hyperplasia. J. Pediatr. Surg. 27: 639-641.
105. RUTGERS, J., R. YOUNG & R. SCULLY. 1988. The testicular "tumor" of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders. Am. J. Surg. Pathol. 12: 503-513.
106. CHAKRABORTY, J., R. FRANCO-SAENZ & K. KROPP. 1983. Electron microscopic study of testicular tumor in congenital adrenal hyperplasia. Hum. Pathol. 14: 151-157.
107. DUPONT, B., S.E. OBERFIELD, E.M. SMITHWICK, et al. 1977. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet 2: 1309-1312.
108. LEVINE, L.S., M. ZACHMANN & M.I. NEW, et al. 1978. Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. N. Engl. J. Med. 299: 911-915.
109. SPEISER, P. & M. NEW. 1987. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 64: 86-91.
110. WHITE, P.C., D. GROSSBERGER, B.J. ONUFER, et al. 1985. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc. Natl. Acad. Sci. USA 82: 1089-1093.
111. CARROLL, M.C., R.D. CAMPBELL & R.R. PORTER. 1985. The mapping of 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc. Natl. Acad. Sci. USA 82: 521-525.
112. HIGASHI, Y., H. YOSHIOKA, M. YAMANE, et al. 1986. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc. Natl. Acad. Sci USA 83: 2841-2845.
113. WHITE, P.C., M.I. NEW & B. DUPONT. 1986. Structure of the human steroid 21-hydroxylase genes. Proc. Natl. Acad. Sci. USA 83: 5111-5115.
114. TUSIE-LUNA, M. & P. WHITE. 1995. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc. Natl. Acad. Sci. USA 92: 10796-10800.
115. WERKMEISTER, J.W., M.I. NEW, B. DUPONT & P.C. WHITE. 1986. Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am. J. Hum. Genet. 39: 461-469.
116. WHITE, P.C., A. VITEK, B. DUPONT & M.I. NEW. 1988. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA 85: 4436-4440.
117. RUMSBY, G., M. CARROLL, R. PORTER, et al. 1986. Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia. J. Med. Genet. 23: 204-209.
118. WEDELL, A., E.M. RITZEN, S.B. HAGLUND & H. LUTHMAN. 1992. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc. Natl. Acad. Sci. USA 89: 7232-7236.
119. RODRIGUES, N.R., I. DUNHAM & C.Y. YU. 1987. Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J. 6: 1653-1661.
120. OWERBACH, D., A. BALLARD & M. DRAZNIN. 1992. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction. J. Clin. Endocrinol. Metab. 74: 553-558.
121. TAJIMA, T., K. FUJIEDA & Y. FUJII-KURIYAMA. 1993. De novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings. J. Clin. Endocrinol. Metab. 77: 86-89.
122. SPEISER, P.W., M.I. NEW & P.C. WHITE. 1988. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1. N. Engl. J. Med. 319: 19-23.
123. TUSIE-LUNA, M.T., P.W. SPEISER, M. DUMIC, et al. 1991. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol. Endocrinol. 5: 685-692.
124. OWERBACH, D., L. SHERMAN, A.L. BALLARD & R. AZZIZ. 1992. Pro-453 to ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. Mol. Endocrinol. 6: 1211-1215.
125. SPEISER, P.W., J. DUPONT, D. ZHU, et al. 1992. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Invest. 90: 584-595.
126. WILSON, R.C., A.B. MERCADO, K.C. CHENG & M.I. NEW. 1995. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J. Clin. Endocrinol. Metab. 80: 2322-2329.
127. KRONE, N., A. BRAUN, A. ROSCHER, et al. 2000. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J. Clin. Endocrinol. Metab. 85: 1059-1065.
128. PANG, S.Y., M.A. WALLACE, L. HOFMAN, et al. 1988. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81: 866-874.
129. ZACHMANN, M., D. TASSINARI & A. PRADER. 1983. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J. Endocrinol. Metab. 56: 222-229.
130. ROSLER, A., E. LEIBERMAN & T. COHEN. 1992. High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am. J. Med. Genet. 42: 827-834.
131. NEW, M., F. LORENZEN, A. LERNER, et al. 1983. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J. Clin. Endocrinol. Metab. 57: 320-326.
132. ZERAH, M., S.Y. PANG, M.I. NEW. 1987. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 65: 227-232.
133. KUTTEN, F. 1986. Late-onset adrenal hyperplasia (letter). N. Engl. J. Med. 314: 450.
134. SPEISER, P.W., N. LAFORGIA, K. KATO, et al. 1990. First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). J. Clin. Endocrinol. Metab. 70: 838-848.
135. JOSSO, N. 2001. Anatomy and endocrinology of fetal sex differentiation. In Endocrinology. L. DeGroot and J. Jameson, Eds.: 1947-1954. W.B. Saunders Company. Philadelphia, PA.
136. WILSON, R.C. et al. 1995. Rapid DNA analysis by allele-specific PCR for detection of mutations in the steroid 21-hydroxylase gene. J. Clin. Endocrinol. Metab. 80(5): 1635-1640.
137. WHITE, P.C. & M.I. NEW. 1988. Molecular genetics of congenital adrenal hyperplasia. Baillieres Clin. Endocrinol. Metab. 2(4): 941-965.
138. FOREST, M. H. BETUEL & M. DAVID. 1989. Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: up-date 88 of the French multicentric study. Endocr. Res. 15(1-2): 277-301.
139. LAJIC, S., A. WEDELL, T. BUI, et al. 1998. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 83: 3872-3880.
140. NEW, M.I. et al. 2001. Extensive personal experience: prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J. Clin. Endocrinol. Metab. 86(12): 5651-5657.
141. SECKL, J.R. & W.L. MILLER. 1997. How safe is long-term prenatal glucocorticoid treatment? JAMA 277(13): 1077-1079.
142. MERCADO, A.B., R.C. WILSON, K.C. CHENG, et al. 1995. Extensive personal experience: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 80: 2014-2020.
143. LARAGH, J. 1971. Aldosteronism in man: factors controlling secretion of the hormone. In The Human Adrenal Cortex. N. Christy, Ed.: 483. Harper and Row. New York.
144. BARTTER, F. 1977. Adrenogenital syndromes from physiology to chemistry. In Congenital Adrenal Hyperplasia. P. Lee, L.P. Plotnick, A. Kowaraski & C. Migeon, Eds.: 9. University Park Press. Baltimore.
145. ROSLER, A., L.S. LEVINE, B. SCHNEIDER, et al. 1977. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 45: 500-512.
146. PANG, S., M. MACGILLIVRAY, M. WANG, et al. 1991. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion. J. Clin. Endocrinol. Metab. 73: 166-174.
147. WINTER, J. 1980. Current approaches to the treatment of congenital adrenal hyperplasia [editorial]. J. Pediatr. 97: 81-82.